Drug treatment targets mutant proteins to stop neurodegenerative diseases
- Written by Albert La Spada, Professor of Neurology, Neurobiology, and Cell Biology, Duke University

Designer therapies are treatments tailored to a specific disease, and nowhere is the need greater for new therapies than in a group of nervous system disorders, known as “neurodegenerative diseases.”
Many of these diseases...
Read more: Drug treatment targets mutant proteins to stop neurodegenerative diseases